A diagnostics company developing and commercializing molecular tests that use tumor and patient biology to inform diagnosis, prognosis, and treatment decisions
A diagnostics company developing and commercializing molecular tests that use tumor and patient biology to inform diagnosis, prognosis, and treatment decisions. Its tests address dermatologic cancers, uveal melanoma, Barrett’s esophagus, and atopic dermatitis.
The top three firms on F4's Biotech & Life Sciences investor list.